Fukuyama City Hospital

Hiroshima 721-8511

0 studies enrolling now · 1 studies all time

What they study most

Muscle-invasive Bladder Cancer

Studies at this site

• A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy — Running, not enrolling